![William Heiden](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
William Heiden
Président chez
MACROGENICS, INC.
Fortune : 836 676 $ au 31/05/2026
Profil
William K.
Heiden currently serves as Non-Executive Chairman at MacroGenics, Inc. since 2022, Independent Director at Atara Biotherapeutics, Inc. since 2015, Director at Third Pole, Inc. since 2021, and Director at both Corea Therapeutics and Boston Collegiate Charter School.
Former roles include President, Chief Executive Officer & Director at AMAG Pharma USA, Inc.; President, Chief Executive Officer & Director at Elixir Pharmaceuticals, Inc. from 2004 to 2008; President, Chief Executive Officer & Director at AMAG Pharmaceuticals, Inc. from 2017 to 2020; Non-Executive Chairman at rEVO Biologics, Inc. from 2012 to 2013; Director at LFB Biotechnologies SASU from 2006 to 2013; Director at Managed Health Care Associates, Inc. from 1996 to 1998; Director at Laboratoire Français du Fractionnement et des Biotechnologies; Director at Pharmaceutical Research & Manufacturers of America from 2016 to 2017; Director at ConjuChem Biotechnologies, Inc.; Vice President-Oncology at Schering-Plough Corp.
from 1987 to 2002; and President & Chief Operating Officer at Praecis Pharmaceuticals, Inc. from 2002 to 2004.
Education includes undergraduate studies at the University of Florida, an MBA from Johnson Graduate School of Management, and graduate studies at Université Catholique de Louvain.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
MACROGENICS, INC. 0,18% | 19/05/2026 | 114 750 ( 0,18% ) | 477 360 $ | 31/05/2026 |
| 09/06/2026 | 34 188 ( 0,38% ) | 359 316 $ | 31/05/2026 |
Postes actifs de William Heiden
| Sociétés | Poste | Début |
|---|---|---|
| ATARA BIOTHERAPEUTICS, INC. | Directeur/Membre du Conseil | 23/11/2015 |
| MACROGENICS, INC. | Président | 22/05/2022 |
Corea Therapeutics | Directeur/Membre du Conseil | - |
Third Pole, Inc.
 Third Pole, Inc. Medical SpecialtiesHealth Technology Develops cardio-pulmonary therapies | Directeur/Membre du Conseil | 24/02/2021 |
Anciens postes connus de William Heiden
| Sociétés | Poste | Fin |
|---|---|---|
| AMAG PHARMACEUTICALS, INC. | Directeur Général | 01/01/2020 |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America BiotechnologyHealth Technology Provides pharmaceutical research and biotechnology services | Directeur/Membre du Conseil | 01/05/2017 |
LFB Biotechnologies SASU
 LFB Biotechnologies SASU BiotechnologyHealth Technology Manufactures biotechnological medicinal products | Directeur/Membre du Conseil | 01/10/2013 |
| REVO BIOLOGICS INC | Président | 26/04/2013 |
Elixir Pharmaceuticals, Inc.
 Elixir Pharmaceuticals, Inc. Investment Trusts/Mutual FundsMiscellaneous Operates as a holding company with interest in manufacturing and developing biopharmaceutical products for the treatment of metabolic diseases | Directeur Général | 01/12/2008 |
Formation de William Heiden
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
74
Relations au 1er degré
18
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 18 |
|---|---|
AMAG Pharma USA, Inc.
 AMAG Pharma USA, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Schering-Plough Corp.
 Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical & health care products | Health Technology |
Praecis Pharmaceuticals, Inc.
 Praecis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs and therapies for the treatment of cancer | Health Technology |
LFB Biotechnologies SASU
LFB Biotechnologies SASU BiotechnologyHealth Technology Manufactures biotechnological medicinal products | Health Technology |
MacroGenics, Inc.
 MacroGenics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes antibody-based therapeutics for the treatment of cancer | Health Technology |
Elixir Pharmaceuticals, Inc.
Elixir Pharmaceuticals, Inc. Investment Trusts/Mutual FundsMiscellaneous Operates as a holding company with interest in manufacturing and developing biopharmaceutical products for the treatment of metabolic diseases | Miscellaneous |
Managed Health Care Associates, Inc.
 Managed Health Care Associates, Inc. Miscellaneous Commercial ServicesCommercial Services Provides management and information technology support services to the healthcare industry | Commercial Services |
University of Florida
 University of Florida Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Johnson Graduate School of Management
 Johnson Graduate School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Laboratoire Français du Fractionnement et des Biotechnologies
 Laboratoire Français du Fractionnement et des Biotechnologies Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets plasma-derived medicinal products & recombinant proteins for the treatment of patients | Health Technology |
Pharmaceutical Research & Manufacturers of America
Pharmaceutical Research & Manufacturers of America BiotechnologyHealth Technology Provides pharmaceutical research and biotechnology services | Health Technology |
AMAG Pharmaceuticals, Inc.
 AMAG Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Université Catholique de Louvain
 Université Catholique de Louvain Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ConjuChem Biotechnologies, Inc.
 ConjuChem Biotechnologies, Inc. Pharmaceuticals: MajorHealth Technology Develops peptide based pharmaceuticals | Health Technology |
rEVO Biologics, Inc.
 rEVO Biologics, Inc. BiotechnologyHealth Technology Develops and commercializes specialty therapeutics to address unmet medical needs in patients with rare, life-threatening conditions | Health Technology |
Atara Biotherapeutics, Inc.
 Atara Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Pioneers the development of transformative therapies for patients with serious diseases including solid tumors, hematologic cancers, and autoimmune diseases | Health Technology |
Third Pole, Inc.
Third Pole, Inc. Medical SpecialtiesHealth Technology Develops cardio-pulmonary therapies | Health Technology |
Corea Therapeutics |
